The Asia Pacific Omics Lab Services Market should witness market growth of 13.4% CAGR during the forecast period (2022-2028).
RNA sequencing uses next-generation sequencing to analyze the amount and sequences of RNA in a sample. Additionally, the Microarray method can simultaneously identify the expression of genes in hundreds of samples. Each transcript in a sample is recognized by RNA sequencing, while microarrays employ hybridization to only identify pre-selected transcripts or genes. The polymerase chain reaction technique is used to make different copies of a single gene in order to recognize and examine a brief sequence of RNA or DNA. Additionally, these techniques allow researchers to examine disorders at the genomic level. Additionally, it helps with the creation of fresh clinical biomarkers, the detection of several molecular diseases, and the analysis of different drugs.
Researchers are working on projects in a range of cutting-edge sectors in laboratories all around the globe that have the potential to shed fresh light on human health and illness. Such 'omics' domains also provide prospects for developing enhanced diagnostics that will fulfill the increasing demands of a healthcare industry centered on the pursuit of precision and customized treatment. They build upon and add to the insights obtained by the Human Genome Project.
As more genomics technologies are accepted and discovered in emerging nations like China and India for the treatment, diagnosis, and prognosis of numerous genetic disorders, including cancer and diabetes, the market is anticipated to grow. Additionally, the rising prevalence of chronic illnesses, including diabetes, rheumatoid arthritis, cancer, Alzheimer's disease, and other neurological disorders, might be linked to the region's expansion.
The Diagnostic Labs market dominated the Asia Pacific Omics Lab Services Market by Business in 2021; thereby, achieving a market value of $18.8 billion by 2028. The Research Institutes market is poised to grow at a CAGR of 13.7% during (2022-2028). Additionally, The Hospitals market would exhibit a CAGR of 13.9% during (2022-2028).
Based on Business, the market is segmented into Diagnostic Labs, Research Institutes, and Hospitals. Based on End-use, the market is segmented into Cancer, Pharmaco, Population Studies & Genealogy, Reproductive, Skincare, Nutrition, Vitamin & Supplements, and Forensics & Others. Based on Type, the market is segmented into Proteomics, Transcriptomic, Metabolomics, Genomics, and Epigenetics. Based on Product, the market is segmented into Hardware Equipment, Testing / Lab Services, and Analytics / Interpretation. Based on Frequency of Service, the market is segmented into Continuous, Repeat, and One-off. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience
RNA sequencing uses next-generation sequencing to analyze the amount and sequences of RNA in a sample. Additionally, the Microarray method can simultaneously identify the expression of genes in hundreds of samples. Each transcript in a sample is recognized by RNA sequencing, while microarrays employ hybridization to only identify pre-selected transcripts or genes. The polymerase chain reaction technique is used to make different copies of a single gene in order to recognize and examine a brief sequence of RNA or DNA. Additionally, these techniques allow researchers to examine disorders at the genomic level. Additionally, it helps with the creation of fresh clinical biomarkers, the detection of several molecular diseases, and the analysis of different drugs.
Researchers are working on projects in a range of cutting-edge sectors in laboratories all around the globe that have the potential to shed fresh light on human health and illness. Such 'omics' domains also provide prospects for developing enhanced diagnostics that will fulfill the increasing demands of a healthcare industry centered on the pursuit of precision and customized treatment. They build upon and add to the insights obtained by the Human Genome Project.
As more genomics technologies are accepted and discovered in emerging nations like China and India for the treatment, diagnosis, and prognosis of numerous genetic disorders, including cancer and diabetes, the market is anticipated to grow. Additionally, the rising prevalence of chronic illnesses, including diabetes, rheumatoid arthritis, cancer, Alzheimer's disease, and other neurological disorders, might be linked to the region's expansion.
The Diagnostic Labs market dominated the Asia Pacific Omics Lab Services Market by Business in 2021; thereby, achieving a market value of $18.8 billion by 2028. The Research Institutes market is poised to grow at a CAGR of 13.7% during (2022-2028). Additionally, The Hospitals market would exhibit a CAGR of 13.9% during (2022-2028).
Based on Business, the market is segmented into Diagnostic Labs, Research Institutes, and Hospitals. Based on End-use, the market is segmented into Cancer, Pharmaco, Population Studies & Genealogy, Reproductive, Skincare, Nutrition, Vitamin & Supplements, and Forensics & Others. Based on Type, the market is segmented into Proteomics, Transcriptomic, Metabolomics, Genomics, and Epigenetics. Based on Product, the market is segmented into Hardware Equipment, Testing / Lab Services, and Analytics / Interpretation. Based on Frequency of Service, the market is segmented into Continuous, Repeat, and One-off. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience
Scope of the Study
By Business
- Diagnostic Labs
- Research Institutes
- Hospitals
By End-Use
- Cancer
- Pharmaco
- Population Studies & Genealogy
- Reproductive
- Skincare
- Nutrition, Vitamin & Supplements
- Forensics & Others
By Type
- Proteomics
- Transcriptomic
- Metabolomics
- Genomics
- Epigenetics
By Product
- Hardware Equipment
- Testing / Lab Services
- Analytics / Interpretation
By Frequency of Service
- Continuous
- Repeat
- One-off
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- BGI Group
- Q2 Solutions (IQVIA)
- Flomics Biotech
- PhenoSwitch Bioscience
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Omics Lab Services Market, by Business
1.4.2 Asia Pacific Omics Lab Services Market, by End-Use
1.4.3 Asia Pacific Omics Lab Services Market, by Type
1.4.4 Asia Pacific Omics Lab Services Market, by Product
1.4.5 Asia Pacific Omics Lab Services Market, by Frequency of Service
1.4.6 Asia Pacific Omics Lab Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Omics Lab Services Market
Chapter 4. Asia Pacific Omics Lab Services Market by Business
4.1 Asia Pacific Diagnostic Labs Market by Country
4.2 Asia Pacific Research Institutes Market by Country
4.3 Asia Pacific Hospitals Market by Country
Chapter 5. Asia Pacific Omics Lab Services Market by End-Use
5.1 Asia Pacific Cancer Market by Country
5.2 Asia Pacific Pharmaco Market by Country
5.3 Asia Pacific Population Studies & Genealogy Market by Country
5.4 Asia Pacific Reproductive Market by Country
5.5 Asia Pacific Skincare Market by Country
5.6 Asia Pacific Nutrition, Vitamin & Supplements Market by Country
5.7 Asia Pacific Forensics & Others Market by Country
Chapter 6. Asia Pacific Omics Lab Services Market by Type
6.1 Asia Pacific Proteomics Market by Country
6.2 Asia Pacific Transcriptomic Market by Country
6.3 Asia Pacific Metabolomics Market by Country
6.4 Asia Pacific Genomics Market by Country
6.5 Asia Pacific Epigenetics Market by Country
Chapter 7. Asia Pacific Omics Lab Services Market by Product
7.1 Asia Pacific Hardware Equipment Market by Country
7.2 Asia Pacific Testing / Lab Services Market by Country
7.3 Asia Pacific Analytics / Interpretation Market by Country
Chapter 8. Asia Pacific Omics Lab Services Market by Frequency of Service
8.1 Asia Pacific Continuous Market by Country
8.2 Asia Pacific Repeat Market by Country
8.3 Asia Pacific One-off Market by Country
Chapter 9. Asia Pacific Omics Lab Services Market by Country
9.1 China Omics Lab Services Market
9.1.1 China Omics Lab Services Market by Business
9.1.2 China Omics Lab Services Market by End-Use
9.1.3 China Omics Lab Services Market by Type
9.1.4 China Omics Lab Services Market by Product
9.1.5 China Omics Lab Services Market by Frequency of Service
9.2 Japan Omics Lab Services Market
9.2.1 Japan Omics Lab Services Market by Business
9.2.2 Japan Omics Lab Services Market by End-Use
9.2.3 Japan Omics Lab Services Market by Type
9.2.4 Japan Omics Lab Services Market by Product
9.2.5 Japan Omics Lab Services Market by Frequency of Service
9.3 India Omics Lab Services Market
9.3.1 India Omics Lab Services Market by Business
9.3.2 India Omics Lab Services Market by End-Use
9.3.3 India Omics Lab Services Market by Type
9.3.4 India Omics Lab Services Market by Product
9.3.5 India Omics Lab Services Market by Frequency of Service
9.4 South Korea Omics Lab Services Market
9.4.1 South Korea Omics Lab Services Market by Business
9.4.2 South Korea Omics Lab Services Market by End-Use
9.4.3 South Korea Omics Lab Services Market by Type
9.4.4 South Korea Omics Lab Services Market by Product
9.4.5 South Korea Omics Lab Services Market by Frequency of Service
9.5 Singapore Omics Lab Services Market
9.5.1 Singapore Omics Lab Services Market by Business
9.5.2 Singapore Omics Lab Services Market by End-Use
9.5.3 Singapore Omics Lab Services Market by Type
9.5.4 Singapore Omics Lab Services Market by Product
9.5.5 Singapore Omics Lab Services Market by Frequency of Service
9.6 Malaysia Omics Lab Services Market
9.6.1 Malaysia Omics Lab Services Market by Business
9.6.2 Malaysia Omics Lab Services Market by End-Use
9.6.3 Malaysia Omics Lab Services Market by Type
9.6.4 Malaysia Omics Lab Services Market by Product
9.6.5 Malaysia Omics Lab Services Market by Frequency of Service
9.7 Rest of Asia Pacific Omics Lab Services Market
9.7.1 Rest of Asia Pacific Omics Lab Services Market by Business
9.7.2 Rest of Asia Pacific Omics Lab Services Market by End-Use
9.7.3 Rest of Asia Pacific Omics Lab Services Market by Type
9.7.4 Rest of Asia Pacific Omics Lab Services Market by Product
9.7.5 Rest of Asia Pacific Omics Lab Services Market by Frequency of Service
Chapter 10. Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 Agilent Technologies, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Acquisition and Mergers:
10.3 Qiagen N.V.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.4 Quest Diagnostics Incorporated
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Illumina, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 BGI Group
10.6.1 Company Overview
10.7 Q2 Solutions (IQVIA)
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Partnerships, Collaborations, and Agreements:
10.8 Flomics Biotech
10.8.1 Company Overview
10.9 PhenoSwitch Bioscience
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- BGI Group
- Q2 Solutions (IQVIA)
- Flomics Biotech
- PhenoSwitch Bioscience
Methodology
LOADING...
